Thomas Nathaniel to Treatment Outcome
This is a "connection" page, showing publications Thomas Nathaniel has written about Treatment Outcome.
Connection Strength
0.751
-
Acute Ischemic Stroke and Heart Failure: Stroke Risk Factors Associated with Exclusion from Thrombolytic Therapy. Clin Appl Thromb Hemost. 2022 Jan-Dec; 28:10760296221116347.
Score: 0.086
-
Risk factors and ambulatory outcome in ischemic stroke patients with pre-stroke depression. J Vasc Nurs. 2021 Dec; 39(4):91-99.
Score: 0.084
-
Clinical Risk Factors Associated with Ambulatory Outcome in Acute Ischemic Stroke Patient Smokers Treated with Thrombolytic Therapy. Am J Med Sci. 2021 10; 362(4):363-374.
Score: 0.083
-
Role of dyslipidemia in ischemic stroke patients treated in the telestroke network. Adv Med Sci. 2021 Sep; 66(2):254-261.
Score: 0.083
-
Thrombolytic therapy in ischemic stroke patients with pre-stroke depression in the telestroke vs non-telestroke. J Stroke Cerebrovasc Dis. 2020 Sep; 29(9):104890.
Score: 0.078
-
Ischemic stroke with a preceding Trans ischemic attack (TIA) less than 24 hours and thrombolytic therapy. BMC Neurol. 2020 May 19; 20(1):197.
Score: 0.077
-
Cholesterol reducer and thrombolytic therapy in acute ischemic stroke patients. Lipids Health Dis. 2020 May 06; 19(1):84.
Score: 0.077
-
Effect of antihypertensive medications on thrombolysis therapy and outcomes in acute ischemic stroke patients. J Clin Hypertens (Greenwich). 2019 02; 21(2):271-279.
Score: 0.071
-
Co-morbid conditions in use of recombinant tissue plasminogen activator (rt-PA) for the treatment of acute ischaemic stroke. Brain Inj. 2016; 30(10):1261-5.
Score: 0.059
-
Tissue plasminogen activator (rt-PA) in acute ischemic stroke: Outcomes associated with ambulation. Restor Neurol Neurosci. 2015; 33(3):301-8.
Score: 0.053